Cough Suppressant Drugs Market, By Disease Type, By Drug Type, By Product Type, By Age Group, By Dosage Form, By Distribution Channel, By Geography

Description

Cough Suppressant Drugs Market is estimated to be valued at USD 1,524.6 Mn in 2026 and is expected to reach USD 1,966.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,524.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	3.70%	2033 Value Projection:	USD 1,966.1 Mn

A cough is a most common symptom of various upper and lower respiratory tract infections. It affects a large proportion of the population leading them to seek medical attention. According to the data published by Journal of the Association of Physicians of India in 2016, cough was identified as the sixth most common reason for hospital outpatient department visits. Cough suppressants, also known as antitussives, are medications that help to suppress cough. Some of the examples of cough suppressants are Dextromethorphan, Codeine, Noscapine, Butamirate, Benzonatate, and Pholcodine. Dextromethorphan and Codeine are the most common and widely used cough suppressant in market.

Market Dynamics

Frequent launch of new cough suppressants in the market by key players is expected to drive the cough suppressant drugs market growth over the forecast period. For instance, in March 2018, Perrigo Company plc. received the FDA approval for the brand OTC equivalent of Mucinex DM Maximum Strength (Guaifenesin and Dextromethorphan Hydrobromide Extended-release Tablets, 1200 mg/60 mg). Mucinex DM Maximum Strength is indicated to control coughs and to break up mucus, making coughs more productive.

Various key players in the market are conducting research and are evaluating safety and efficacy of various drugs for the treatment of cough. Such initiatives taken by companies is expected to lead to the development of new cough suppressant drugs.

For instance, CSPC ZhongQi Pharmaceutical Technology Co., Ltd. is evaluating the efficacy and safety of benzonatate soft capsules for improving adult cough symptoms, wherein the study is currently (2018) under phase 3 clinical trial.

Moreover, high prevalence of cough is expected to increase the demand for cough suppressant drugs, thereby driving the market growth. For instance, according to the study published by the National Center for Biotechnology Information in 2013, cough is a very common condition and around 12% of the people in Britain experience chronic cough, daily or weekly.

Key features of the study

This report provides in-depth analysis of cough suppressant drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players
It profiles leading players in the global cough suppressant drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Perrigo Company plc, Vernalis plc, Tris Pharma Inc., Pfizer Inc., Aytu BioScience, Inc., Acella Pharmaceuticals LLC, Mayne Pharma Inc., Taro Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd, and GlaxoSmithKline plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global cough suppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cough suppressant drugs market

Market Segmentation

Disease Type Insights (Revenue, USD Mn, 2026 - 2033)
- Dry Cough
- Wet Cough
Drug Type Insights (Revenue, USD Mn, 2026 - 2033)
- Dextromethorphan
- Codeine
- Noscapine
- Butamirate
- Benzonatate
- Pholcodine
- Others
Product Type Insights (Revenue, USD Mn, 2026 - 2033)
- Over-the-counter (OTC)
- Prescription Drug
Age Group Insights (Revenue, USD Mn, 2026 - 2033)
- Pediatric
- Adult
Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)
- Hospital
- Retail Pharmacy
- Online Pharmacy
- Others
Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Perrigo Company plc
- Vernalis plc
- Tris Pharma Inc.
- Pfizer Inc.
- Aytu BioScience, Inc.
- Acella Pharmaceuticals LLC
- Mayne Pharma Inc.
- Taro Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC
- Aurobindo Pharma Ltd
- GlaxoSmithKline plc.

Product Code: CMI2427

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Disease Type
- Market Snippet, By Drug Type
- Market Snippet, By Product Type
- Market Snippet, By Age Group
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Cough Suppressant Drugs Market, By Disease Type, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Dry Cough
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Wet Cough
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Cough Suppressant Drugs Market, By Drug Type, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Dextromethorphan
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Codeine
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Noscapine
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Butamirate
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Benzonatate
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pholcodine
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Cough Suppressant Drugs Market, By Product Type, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Over-the-counter (OTC)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Prescription Drug
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Cough Suppressant Drugs Market, By Age Group, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pediatric
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Adult
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

8. Global Cough Suppressant Drugs Market, By Distribution Channel, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospital
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Retail Pharmacy
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Online Pharmacy
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

9. Global Cough Suppressant Drugs Market, By Region, 2026-2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Disease Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Drug Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Age Group, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Perrigo Company plc
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Vernalis plc
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Tris Pharma Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Pfizer Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Aytu BioScience, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Acella Pharmaceuticals LLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Mayne Pharma Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Taro Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Amneal Pharmaceuticals LLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Aurobindo Pharma Ltd
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- GlaxoSmithKline plc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates

11. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. Section

References
Research Methodology
About Us and Sales Contact